Ureaplasma parvum causes hyperammonemia presenting as refractory status epilepticus after kidney transplant.


Journal

Journal of critical care
ISSN: 1557-8615
Titre abrégé: J Crit Care
Pays: United States
ID NLM: 8610642

Informations de publication

Date de publication:
06 2020
Historique:
received: 11 12 2019
revised: 02 02 2020
accepted: 05 02 2020
pubmed: 18 2 2020
medline: 18 5 2021
entrez: 17 2 2020
Statut: ppublish

Résumé

Alert intensivists about the diagnostic pitfalls arising from hyperammonemia due to Ureaplasma infections in post-transplant patients. Clinical observation of one patient. A 65-year-old female with a medical history of semi-recent kidney transplant was admitted to the Intensive Care Unit for refractory status epilepticus. There were no lesions on brain imaging. Bacterial cultures and viral PCR of cerebrospinal fluid were negative. The first blood ammonia level measured on day 2 was 13 times the normal level, but biological liver tests were normal. The persistence of elevated ammonia levels led to the initiation of symptomatic ammonia lowering-treatments and continuous renal replacement therapy, which led to its decrease without normalization. An Ureaplasma spp infection was then diagnosed. Levofloxacin and doxycyline were administered resulting in normalization of ammonia levels within 48 h. However repeat MRI showed diffuse cortical cytotoxic edema and the patient remained in a minimally conscious state. She eventually died 4 months later from a recurrent infection. Ureaplasma infection must be suspected in cases of neurological symptoms associated with hyperammonemia without liver failure, following an organ transplant. Only urgent treatment could improve the prognosis and prevent severe neurological damage or death.

Identifiants

pubmed: 32062289
pii: S0883-9441(19)31890-8
doi: 10.1016/j.jcrc.2020.02.003
pii:
doi:

Substances chimiques

Immunosuppressive Agents 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

79-83

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflict of interest. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Auteurs

Camille Legouy (C)

Sainte Anne Hospital, Department of Neurointensive Care, Paris, France.

Alice Hu (A)

Fondation Ophtalmologique Adolphe de Rothschild, Department of Neurointensive Care, Paris, France.

Fanny Mochel (F)

Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Department of Genetics, Paris, France.

Nicolas Weiss (N)

Assistance Publique - Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Department of Neurointensive Care, Paris, France.

Adrien Collin (A)

Fondation Ophtalmologique Adolphe de Rothschild, Department of Neuroradiology, Paris, France.

Sabine Pereyre (S)

French National Reference Center for bacterial STI, Pellegrin Hospital, Bordeaux, France.

Mathilde Perrin (M)

Fondation Ophtalmologique Adolphe de Rothschild, Department of Neurointensive Care, Paris, France.

Nicolas Engrand (N)

Fondation Ophtalmologique Adolphe de Rothschild, Department of Neurointensive Care, Paris, France. Electronic address: nengrand@fo-rothschild.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH